Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R)

V. Hainer, I. Aldhoon Hainerová, M. Kunešová, R. Taxová Braunerová, H. Zamrazilová, B. Bendlová

. 2020 ; 69 (Suppl 2) : S245-S254. [pub] 20200930

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21022246

Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21022246
003      
CZ-PrNML
005      
20210914152208.0
007      
ta
008      
210902s2020 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934512 $2 doi
035    __
$a (PubMed)33094623
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hainer, Vojtěch, $d 1944- $7 jn19990209207 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
245    10
$a Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R) / $c V. Hainer, I. Aldhoon Hainerová, M. Kunešová, R. Taxová Braunerová, H. Zamrazilová, B. Bendlová
504    __
$a Literatura
520    9_
$a Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.
650    _2
$a zvířata $7 D000818
650    _2
$a látky proti obezitě $x farmakologie $7 D019440
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a lidé $7 D006801
650    _2
$a cílená molekulární terapie $7 D058990
650    12
$a mutace $7 D009154
650    _2
$a obezita $x farmakoterapie $x genetika $x metabolismus $7 D009765
650    _2
$a receptor melanokortinový typ 4 $x genetika $x metabolismus $7 D044105
650    _2
$a alfa-MSH $x farmakologie $7 D000521
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Aldhoon Hainerová, Irena, $d 1978- $7 xx0062316 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic $u Department of Pediatrics, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Kunešová, Marie, $d 1951- $7 jn19990209456 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Braunerová, Radka $7 xx0092176 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Zamrazilová, Hana $7 xx0092178 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Bendlová, Běla, $d 1962- $7 jo20000074069 $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, Suppl 2 (2020), s. S245-S254
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33094623 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20210902 $b ABA008
991    __
$a 20210908143300 $b ABA008
999    __
$a ok $b bmc $g 1697043 $s 1142720
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c Suppl 2 $d S245-S254 $e 20200930 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20210902

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...